Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/16/2013 | 03:34am CET

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664
carolyn@burzynskiclinic.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
06:15p DETECTIVES : Porter woman purchased $300K on company's dime
06:14pDJLONDON MARKETS : FTSE 100 Slides Most Since June As May Says Britain Will Leave EU's Single Market
06:14p Barona Creek Golf Club Ranked One of the Top 10 Best Casino Golf Courses in the Nation by Golfweek Magazine
06:14p A.M. BEST REQUESTS COMMENTS ON DRAFT CRITERIA : Rating Monoline Financial Guarantors in the Public Finance Sector
06:14p CRAZY HORSE RESOURCES : Files Independent Technical Report on Taysan Project
06:13p PACIFIC THERAPEUTICS : Tower One to Attend the Cantech Conference
06:13p NEW ENTERPRISE STONE & LIME CO., INC. : Files 10-Q and Announces 2017 Third Quarter Earnings Conference Call
06:13p AGILE THERAPEUTICS INC : Khang & Khang LLP Announces a Class Action Lawsuit against Agile Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
06:12p Swiss watchmakers cautiously optimistic for U.S., China in 2017
06:11p NATIONAL WASTE MANAGEMENT : NWMH) Turns Trash into Treasure, Records Strong Revenue Growth
Latest news
Advertisement
Hot News 
3.18%REYNOLDS AMERICAN : BAT Agrees to Pay $49 Billion to Take Full Control of Reynolds -- Update
-3.83%BRITISH AMERICAN TOBACCO : Agrees to Pay $49 Billion to Take Full Control of Reynolds American
4.77%CHOCOLADEFABRIKEN LINDT & SPRUENGLI : Lindt sales rise, sees profit boost from lower tax rate
2.26%GEBERIT : boosts 2016 sales 8.3 percent after strong fourth quarter
5.14%NOBLE ENERGY : to Buy Oil and Gas Company Clayton Williams -- 2nd Update
Most Read News
11:59a BMW, UK car industry say Britain needs to keep tariff-free EU trade
11:18a Trump, Brexit uncertainty hit stocks and dollar, gold jumps
10:45a TSX barely lower as resource stock gains offset bank, rails
06:59a HSBC : China unveils new plan to further open economy to foreign investment
06:29a Japan brewer Asahi says it is open to more M&A after Europe beer deals
Most recommended articles
08:15aDJS&P 500, Nasdaq Futures -- Technical Analysis
12:12p Swiss watchmakers cautiously optimistic for U.S., China in 2017
12:09p BOEING : Upbeat Boeing CEO says meeting with Trump 'very productive'
12:07p FTSE falls most since June 2016 after PM May's Brexit speech
12:03pDJMORGAN STANLEY : Posts Biggest Fourth-Quarter Profit Since Crisis -- 5th Update